Patents by Inventor William A. Van Sickle

William A. Van Sickle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Triaryl-ethylene derivatives
    Patent number: 5684004
    Abstract: The present invention relates to novel triaryl-ethylene derivatives that are useful as anti-neoplastic agents, antiatherosclerotic agents, and hypocholesterolemic agents.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: November 4, 1997
    Assignee: Merrell Pharmaceuticals, Inc.
    Inventors: Donald A. Kaplan, Donald P. Matthews, Alan J. Bitonti, William A. Van Sickle
  • Triaryl-ethylene derivatives
    Patent number: 5525633
    Abstract: The present invention relates to novel triaryl-ethylene derivatives that are useful as anti-neoplastic agents, antiatherosclerotic agents, and hypocholesterolemic agents.
    Type: Grant
    Filed: June 15, 1994
    Date of Patent: June 11, 1996
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Donald P. Matthews, Alan J. Bitonti, William A. Van Sickle, Donald A. Kaplan
  • Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis
    Patent number: 5278171
    Abstract: The present invention provides certain novel azadecalin amides and thioamides which are useful as inhibitors of cholesterol biosynthesis and as agents which lower total serum cholesterol in patients in need thereof.
    Type: Grant
    Filed: October 15, 1991
    Date of Patent: January 11, 1994
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Marion W. Wannamaker, William A. Van Sickle, William R. Moore
  • Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis
    Patent number: 5084461
    Abstract: The present invention provides certain novel azadecalin amides and thioamides which are useful as inhibitors of cholesterol biosynthesis and as agents which lower total serum cholesterol in patients in need thereof.
    Type: Grant
    Filed: March 27, 1991
    Date of Patent: January 28, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Marion W. Wannamaker, William A. Van Sickle, William R. Moore